Perflubron decreases inflammatory cytokine production by human alveolar macrophages
- 1 December 1997
- journal article
- laboratory investigations
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 25 (12) , 2045-2047
- https://doi.org/10.1097/00003246-199712000-00023
Abstract
Objective To determine whether inflammatory cytokine production by stimulated human alveolar macrophages is affected by perflubron exposure. Design Controlled laboratory investigation of alveolar macrophage function in vitro. Setting Research laboratory. Subjects Cultured alveolar macrophages obtained by bronchoalveolar lavage from eleven normal volunteers. Interventions Endotoxin-stimulated alveolar macrophages were treated with perflubron. Measurements and Main Results Alveolar macrophages were stimulated for 1 hr with lipopolysaccharide and then treated with perflubron for 23 hrs. Cell-free supernatants were collected and cytokines were assayed by enzyme-linked immunosorbent assay. Tumor necrosis factor-alpha, interleukin-1, and interleukin-6 were stimulated by lipopolysaccharide (endotoxin) and all of these cytokines were significantly (p < .05) inhibited by perflubron. Cell viability was not affected by perflubron. Basal cytokine concentrations from unstimulated alveolar macrophages were not altered by perflubron. Conclusions Exposure of stimulated human alveolar macrophages to perflubron in vitro decreases cytokine production. This observation suggests that perflubron may have anti-inflammatory activity. (Crit Care Med 1997; 25:2045-2047)Keywords
This publication has 18 references indexed in Scilit:
- A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophagesCritical Care Medicine, 1995
- Improvement of Gas Exchange, Pulmonary Function, and Lung Injury With Partial Liquid VentilationChest, 1995
- Perfluorocarbon-associated gas exchange in gastric aspirationCritical Care Medicine, 1994
- Liquid ventilationPediatric Pulmonology, 1992
- Synthetic Surfactant (Exosurf) Inhibits Endotoxin-stimulated Cytokine Secretion by Human Alveolar MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- Tumor Necrosis Factor Levels in Serum and Bronchoalveolar Lavage Fluid of Patients with the Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1991
- Plasma Tumor Necrosis Factor in Patients with Septic Shock: Mortality Rate, Incidence of Adult Respiratory Distress Syndrome, and Effects of Methylprednisolone AdministrationAmerican Review of Respiratory Disease, 1989
- Elevated lnterleukin-1 Release by Human Alveolar Macrophages during the Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1989
- Cachetin/TNF-α in Septic Shock and Septic Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1988
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986